DaVita has experienced difficulty enrolling more patients in its dialysis program, reporting a decline in its patients since ...

BiVACOR has made the world’s first titanium heart and is hoping to manufacture the device commercially in Australia and the ...

The stock market is in correction territory, with risks from protectionism reminiscent of the 1920s, potentially leading to a ...

We recently compiled a list of the 10 Best Delivery Stocks to Buy According to Billionaires. In this article, we are going to ...

Twentyeight Health's Q1 Momentum Mara's addition to the team is another mark on Twentyeight Health's timeline of rapid growth. During Q1 2025, Twentyeight Health reached significant milestones toward ...

Celltrion today announced the U.S. launch of STEQEYMA��(ustekinumab-stba), a biosimilar to STELARA� (ustekinumab), following approval by the U.S. Food and Drug Administration (FDA) in December 2024.

This includes even the more remote areas, where many of Taiwan’s hi-tech industrial parks are located. Read more at ...

Health is pioneering a new model of cognitive care, designed to increase access, improve outcomes, and support both patients and healthcare ...

The International Monetary Fund (IMF) recently commended Egypt's efforts to rebuild market confidence and stabilize the economy, citing a recovery in economic activity and progress in restoring ...

Significant events during 2024 NAV as of 31 December 2024: €1,280.0m (€35.06 per share), up 1.4% including the dividend paid in May 2024 (€1.08 per share) Weighted average EBITDA of portfolio companie ...